Passive perinatal immunotherapy via transamniotic antibody delivery.

[1]  D. Zurakowski,et al.  Hematogenous Donor Cell Routing Pathway after Transamniotic Stem Cell Therapy. , 2020, Stem cells and development.

[2]  D. Zurakowski,et al.  Strategies in adjusting for multiple comparisons: A primer for pediatric surgeons. , 2020, Journal of pediatric surgery.

[3]  D. Zurakowski,et al.  Calculation of Confidence Intervals for Differences in Medians Between Groups and Comparison of Methods. , 2019, Anesthesia and analgesia.

[4]  B. Firek,et al.  Maternal IgA protects against the development of necrotizing enterocolitis in preterm infants , 2019, Nature Medicine.

[5]  D. Zurakowski,et al.  Donor mesenchymal stem cell linetics after transamniotic stem cell therapy (TRASCET) for experimental spina bifida. , 2018, Journal of pediatric surgery.

[6]  G. Fouda,et al.  The Impact of IgG Transplacental Transfer on Early Life Immunity , 2018, ImmunoHorizons.

[7]  D. Zurakowski,et al.  Fetal bone marrow homing of donor mesenchymal stem cells after transamniotic stem cell therapy (TRASCET). , 2017, Journal of pediatric surgery.

[8]  A. Ohlsson,et al.  Intravenous immunoglobulin for suspected or proven infection in neonates. , 2013, The Cochrane database of systematic reviews.

[9]  G. Enders,et al.  Use of cytomegalovirus hyperimmunoglobulin for prevention of congenital cytomegalovirus disease: a retrospective analysis , 2012, Journal of perinatal medicine.

[10]  K. Furuya,et al.  Fetal intraperitoneal injection of immunoglobulin diminishes alloimmune hemolysis , 2011, Journal of Perinatology.

[11]  S. Akilesh,et al.  FcRn: the neonatal Fc receptor comes of age , 2007, Nature Reviews Immunology.

[12]  A. Kriplani,et al.  Fetal Intravenous Immunoglobulin Therapy in Rhesus Hemolytic Disease , 2006, Gynecologic and Obstetric Investigation.

[13]  N. Tsurushita,et al.  An Engineered Human IgG1 Antibody with Longer Serum Half-Life , 2006, The Journal of Immunology.

[14]  E. Jauniaux,et al.  Materno-fetal immunoglobulin transfer and passive immunity during the first trimester of human pregnancy. , 1995, Human reproduction.

[15]  M. Eibl,et al.  The anti‐inflammatory effect of an oral immunoglobulin (IgA‐IgG) preparation and its possible relevance for the prevention of necrotizing enterocolitis , 1994, Acta paediatrica (Oslo, Norway : 1992). Supplement.

[16]  M. Eibl,et al.  Prevention of necrotizing enterocolitis in low-birth-weight infants by IgA-IgG feeding. , 1988, The New England journal of medicine.